MOLECULAR TYPES IN THE PROGNOSIS OF PAPILLARY THYROID CANCER BASED ON THE ANALYSIS OF THE STATUS OF BRAF V600E, INDEX AND KI-67 EXPRESSION
- 作者: Ivanov A.1, Avdalyan A.1, Gerval'd V.1, Lushnikova E.2, Zorkina Y.3, Kruglova N.1, Lazarev A.1
-
隶属关系:
- Altai Branch of the N.N. Blokhin Russian Cancer Research Center
- Institute of Molecular Pathology and Pathomorphology
- Altai Krai Oncology Centre
- 期: 卷 22, 编号 4 (2017)
- 页面: 188-193
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40366
- DOI: https://doi.org/10.18821/1028-9984-2017-22-4-188-193
- ID: 40366
如何引用文章
全文:
详细
作者简介
Anatoly Ivanov
Altai Branch of the N.N. Blokhin Russian Cancer Research Center
Email: Anatolij0199@yandex.ru
MD, Researcher of the Laboratory of Investigations of Molecular Genetic Characteristics of Tumors of the Altai Branch of the N.N. Blokhin Russian Cancer Research Center; Barnaul, 656049, Russian Federation Barnaul, 656049, Russian Federation
A. Avdalyan
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
V. Gerval'd
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
E. Lushnikova
Institute of Molecular Pathology and PathomorphologyNovosibirsk, 630117, Russian Federation
Yu. Zorkina
Altai Krai Oncology CentreBarnaul, 656043, Russian Federation
N. Kruglova
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
A. Lazarev
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
参考
- Pellegriti G., Scollo C., Lumera G., Regalbuto C., Vigneri R., Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. Journal of Clinical Endocrinology and Metabolism. 2004; 89(8): 3713-20.
- Page C., Biet A., Boute P., Cuvelier P., Strunski V. Aggressive papillary thyroid microcarcinoma. European Archives of Oto-Rhino-Laryngology. 2009; 266(12): 1959-63.
- Yu X.M., Wan Y., Sippel R.S., Chen H. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18445 cases. Annals of Surgery. 2011; 254(4): 653-60.
- Basolo F., Torregrossa L., Giannini R., Miccoli M., Lupi C., Sensi E. et al. Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases. J. Clin. Endocrinol. Metab. 2010; 95(9): 4197-205.
- Lee K.J., Cho Y.J., Kim S.J. et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World Journal of Surgery. 2011; 35(2): 318-23.
- Vasileiadis I., Karakostas E., Charitoudis G. et al. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. European Journal of Clinical Investigation. 2012; 42(6): 657-64.
- Kebebew E., Weng J., Bauer J., Ranvier G., Clark O.H., Duh Q.Y. et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Annals of Surgery. 2007; 246: 466-70.
- Nikiforova M., Kimura E., Gandhi M., Biddinger P., Knauf J., Basolo F. et al. BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 2003; 88(11): 5399-404.
- Xing M., Westra W., Tufano R., Cohen Y., Rosenbaum E., Rhoden K. et al. BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 2005; 90(12): 6373-9.
- Lupi C., Giannini R., Ugolini C., Proietti A., Berti P., Minuto M. et al. Extensive Clinical Experience. Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2007; 92(11): 4085-90.
- Ahn D., Park J.S., Sohn J.H., Kim J.H., Park S.K., Seo A.N. et al. BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma. Auris Nasus Larynx. 2012; 39: 198-203.
- Puxeddy Е., Moretti S., Elisei R., Romei C., Pascucci R., Martinelli M. BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 2004; 89(5): 2414-20.
- Liu R., Chen Y., Chou F., Li C., Wu W., Tsai P. et al. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clin. Endocrinol. 2005; 63: 461-6.
- Ito Y., Miyauchi A. Prognostic Factors of Papillary and Follicular Carcinomas in Japan Based on Data of Kuma Hospital. J. Thyroid. Res. 2012; 973497.
- Barbaro D., Incensati R.M., Materazzi G., Boni G., Grosso M., Panicucci E. et al. The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis. Endocrine. 2014; 45(3): 462-8.
- Wallin G., Backdahl M., Christensson B., Grimelius L., Auer G. Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells. Anal. Quant. Cytol. Histol. 1992; 14(4): 296-303.
- Basolo F., Pollina L., Fontanini G., Fiore L., Pacini F., Baldanzi A. Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. Br. J. Cancer. 1997; 75(4): 537-41.
- Katoh R., Bray C.E., Suzuki K., Komiyama A., Hemmi A., Kawaoi A. et al. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum. Pathol. 1995; 26(2): 139-46.
- Saki N., Bonab H.P., Ranjbari N., Rahim F., Nikakhlagh S. Correlation of KI-67/MIB-1 in the Papillary Macro and Micro-carcinomas of the Thyroid Gland with the Prognosis of the Patients. Asian Journal of Cell Biology. 2015; 10: 13-8.
- Ito Y., Miyauchi A., Kakudo K., Hirokawa M., Kobayashi K., Miya A. Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J. Surg. 2010; 34: 3015-21.
- Sugitani I., Yanagisawa A., Shimizu A., Kato M., Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J. Surg. 1998; 22(7): 731-7.